We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+0.55%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$48B
AUM Growth
-$1.59B
(-3.2%)
Cap. Flow
-$1.46B
Cap. Flow
% of AUM
-3.05%
Top 10 Holdings %
Top 10 Hldgs %
24.06%
Holding
1,904
New
84
Increased
534
Reduced
502
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$60.6M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$50.8M |
| 3 |
Mastercard
MA
|
+$43.1M |
| 4 |
Analog Devices
ADI
|
+$40.3M |
| 5 |
Broadcom
AVGO
|
+$40.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$92.3M |
| 2 |
NVIDIA
NVDA
|
+$92.1M |
| 3 |
Eli Lilly
LLY
|
+$80.8M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$74.2M |
| 5 |
Microsoft
MSFT
|
+$69.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.14% |
| 2 | Financials | 15.08% |
| 3 | Healthcare | 14.69% |
| 4 | Consumer Discretionary | 11.11% |
| 5 | Communication Services | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Elevance Health
ELV
$82B
| $83.4M | 0.17% |
223,676
+48,039
| +27% | +$18.3M |
|
127
Teladoc Health
TDOC
$1.59B
| $82.6M | 0.17% |
651,280
-48,282
| -7% | -$7.03M |
|
128
Vertex Pharmaceuticals
VRTX
$122B
| $81.1M | 0.17% |
447,212
-158,321
| -26% | -$30.9M |
|
129
Boston Scientific
BSX
$68.5B
| $79.8M | 0.17% |
1,838,293
+659,331
| +56% | +$29.2M |
|
130
RTX Corp
RTX
$294B
| $79.5M | 0.17% |
925,294
+193,361
| +26% | +$16.5M |
|
131
Carrier Global
CARR
$56.7B
| $79.3M | 0.17% |
1,532,879
-107,006
| -7% | -$5.76M |
|
132
Marriott International
MAR
$100B
| $78.6M | 0.16% |
530,679
-17,729
| -3% | -$2.48M |
|
|
FISV
133
Fiserv Inc
FISV
$27.8B
| $78.5M | 0.16% |
723,077
+201,330
| +39% | +$22.5M |
|
|
WNS
134
DELISTED
WNS Holdings
WNS
| $78.4M | 0.16% |
958,880
+63,270
| +7% | +$5.17M |
|
135
Ryder
R
$10.1B
| $77.1M | 0.16% |
931,646
-2,618
| -0.3% | -$202K |
|
136
Fidelity National Information Services
FIS
$22.3B
| $72.8M | 0.15% |
598,350
-211,590
| -26% | -$28.4M |
|
137
US Bancorp
USB
$99.3B
| $72.3M | 0.15% |
1,216,005
+434,915
| +56% | +$24.8M |
|
138
HEICO Corp Class A
HEI.A
$35.8B
| $70.2M | 0.15% |
593,138
+45,163
| +8% | +$5.39M |
|
|
XYZ
139
Block Inc
XYZ
$47.2B
| $68.3M | 0.14% |
284,915
+139,834
| +96% | +$35.9M |
|
140
Aptiv
APTV
$12B
| $67.2M | 0.14% |
450,778
-26,622
| -6% | -$4.15M |
|
141
Ametek
AME
$54.8B
| $65.6M | 0.14% |
528,924
-75,687
| -13% | -$10.2M |
|
142
DuPont de Nemours
DD
$18.6B
| $65M | 0.14% |
761,081
-17,869
| -2% | -$1.66M |
|
143
iShares MSCI India ETF
INDA
$6.75B
| $64.9M | 0.14% |
1,333,480
+10,996
| +0.8% | +$513K |
|
144
iShares MSCI EAFE ETF
EFA
$76.5B
| $64.8M | 0.14% |
830,302
+55,000
| +7% | +$4.4M |
|
|
ATH
145
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $64.4M | 0.13% |
934,967
| – | – |
|
146
Exelon
EXC
$48.6B
| $64.1M | 0.13% |
1,857,663
+178,577
| +11% | +$6.1M |
|
147
McKesson
MCK
$100B
| $63.7M | 0.13% |
319,423
+39,452
| +14% | +$7.89M |
|
148
Kinder Morgan
KMI
$70.9B
| $63M | 0.13% |
3,763,886
-109,001
| -3% | -$1.85M |
|
149
CBRE Group
CBRE
$41.8B
| $62.6M | 0.13% |
643,057
-363,064
| -36% | -$33.7M |
|
150
Accenture
ACN
$94.4B
| $62M | 0.13% |
193,688
+55,858
| +41% | +$18.2M |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, Ensign Peak Advisors held 1,904 positions worth $48B, down 3.2% from $49.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Ensign Peak Advisors withdrew a net $1.46B in Q3 2021, closing 55 positions and reducing 502 holdings. Its most notable exit was Root, an estimated $29.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Ensign Peak Advisors opened a new position in State Street SPDR S&P Biotech ETF worth $37.7M.
- Ensign Peak Advisors's largest Q3 2021 buy was State Street SPDR S&P Biotech ETF: 300,000 shares worth $37.7M.
- Ensign Peak Advisors added most to AbbVie in Q3 2021, an estimated $60.6M increase.
- Ensign Peak Advisors's biggest Q3 2021 reduction was Walt Disney, cutting an estimated $92.3M.
- Ensign Peak Advisors fully exited Root in Q3 2021, selling an estimated $29.6M.
- Ensign Peak Advisors's ten largest holdings make up 24% of its $48B portfolio in Q3 2021.
- Ensign Peak Advisors opened 84 new positions and closed 55 in Q3 2021.
- Ensign Peak Advisors's portfolio value fell 3.2% quarter-over-quarter to $48B.
Based on Ensign Peak Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.